摘要:
A process assembles and/or reassembles a software application. In an embodiment, assemblies are loaded from an architecture description markup language (ADML) document. Class objects and type objects are activated based on the ADML document. Components and connectors are created based on the ADML document. The components are serialized, and an architecture is assembled based on connections described in the ADML document. A main active component designated in the ADML document is then activated.
摘要:
A method of producing glass sheets includes the step of fusion drawing a glass ribbon along a draw direction into a viscous zone downstream from a root of a forming wedge. The method further includes the step of drawing the glass ribbon into a setting zone downstream from the viscous zone, wherein the glass ribbon is set from a viscous state to an elastic state. The method further includes the steps of drawing the glass ribbon into an elastic zone downstream from the setting zone and stabilizing a region of the glass ribbon in the elastic zone along a width of the glass ribbon extending transverse with respect to the draw direction. A predetermined pressure differential between a first side and a second side of the glass ribbon is used to create the stabilized region. The method further includes the step of cutting a glass sheet from the glass ribbon, wherein the stabilized region inhibits shape instabilities from propagating upstream through the glass ribbon to the setting zone.
摘要:
This application relates to recombinant human interferon-like proteins. In one embodiment a recombinant protein created by gene shuffling technology is described having enhanced anti-viral and anti-proliferative activities in comparison to naturally occurring human interferon alpha 2b (HuIFN-α2b). The invention encompasses a polynucleotide encoding the protein and recombinant vectors and host cells comprising the polynucleotide. Preferably the polynucleotide is selected from the group of polynucleotides each having a sequence at least 93% identical to SEQ ID: No. 1 and the protein is selected from the group of proteins each having an amino acid sequence at least 85% identical to SEQ ID No: 2. The proteins and compositions comprising the proteins can be used for treatment of conditions responsive to interferon therapy, such as viral diseases and cancer.
摘要:
A system for a data stream management system includes a filter transport aggregate for a high speed input data stream with a plurality of packets each packet comprising attributes. The system includes an evaluation system to evaluate the high speed input data stream and partitions the packets into groups the attributes and a table, wherein the table stores the attributes of each packets using a hash function. A phantom query is used to define partitioned groups of packets using attributes other than those used to group the packets for solving user queries without performing the user queries on the high speed input data stream.
摘要:
A pre-plating solution for making a printed circuit board includes carbon nanotubes of 0.01-3 wt %, a surfactant of 0.01-4 wt %, an alkaline substance of 0.01-l wt % and a solvent. A method for preparing a pre-plating solution comprising the steps of: providing a plurality of carbon nanotubes; purifying the carbon nanotubes; treating the purified carbon nanotubes with an acid; mixing the treated carbon nanotubes, an alkaline substance and a solvent to form suspension; and adding surfactant into suspension.
摘要:
Disclosed herein are a method and system for creating visual programs using a graphical notation. In a preferred embodiment, a visual programming system is provided. The visual programming system comprises (a) a processor; (b) data storage; and (c) program code stored in the data storage and executable by the processor. The program code is executable to implement a graphical notation that can be used to create visual programs displayable on a monitor, wherein the graphical notation comprises objects and connectors that connect the objects to other objects, wherein the objects comprise control flow objects and standard objects, and wherein the control flow objects substantially direct execution of the visual program. The program code is further executable to implement a visual program engine operable to execute visual programs created using the graphical notation, thereby causing the processor to carry out processes as indicated by the visual programs.
摘要:
The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR delta modulators to treat or inhibit the progression of, for example, dyslipidemia.
摘要:
A method for performing entropy coding comprising the steps of (A) receiving an input stream and side information and (B) replacing the input stream with an index to a list of a number of valid input streams that satisfy all constraints associated with each specific type of the side information, where the list of the number of valid input streams that satisfy all constraints associated with each specific type of side information is based on an amount of redundancy in a system.
摘要:
A process assembles and/or reassembles a software application. In an embodiment, assemblies are loaded from an architecture description markup language (ADML) document. Class objects and type objects are activated based on the ADML document. Components and connectors are created based on the ADML document. The components are serialized, and an architecture is assembled based on connections described in the ADML document. A main active component designated in the ADML document is then activated.
摘要:
A recombinant fusion protein comprising a human erythropoietin peptide portion linked to an immunoglobulin peptide portion is described. The fusion protein has a prolonged half-life in vivo in comparison to naturally occurring or recombinant native human erythropoietin. In one embodiment of the invention, the protein has a half-life in vivo at least three fold higher than native human erythropoietin. The fusion protein also exhibits enhanced erythropoietic bioactivity in comparison to native human erythropoietin. In one embodiment, the fusion protein comprises the complete peptide sequence of a human erythropoietin (EPO) molecule and the peptide sequence of an Fc fragment of human immunoglobulin IgG1. The Fc fragment in the fusion protein includes the hinge region, CH2 and CH3 domains of human immunoglobulin IgG1. The EPO molecule may be linked directly to the Fc fragment to avoid extraneous peptide linkers and lessen the risk of an immunogenic response when administered in vivo. In one embodiment the hinge region is a human Fc fragment variant having a non-cysteine residue at amino acid 6. The invention also relates to nucleic acid and amino acid sequences encoding the fusion protein and transfected cell lines and methods for producing the fusion protein. The invention further includes pharmaceutical compositions comprising the fusion protein and methods of using the fusion protein and/or the pharmaceutical compositions, for example to stimulate erythropoiesis in subjects in need of therapy.